Autolus Therapeutics plc (AUTL) Revenue & EPS Growth Rates 2026 | EvidInvest

Growth Analysis - AUTL

Financial Metrics

Revenue Trends

Period:

CAGR Performance

Revenue

1Y Growth644.94%

5Y CAGRN/A

10Y CAGRN/A

Net Income

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EPS

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBIT

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

EBITDA

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Capex

1Y Growth-13.73%

5Y CAGR5.34%

10Y CAGRN/A

Equity

1Y Growth-58.32%

5Y CAGR-3.24%

10Y CAGRN/A

Cash Flow

1Y GrowthN/A

5Y CAGRN/A

10Y CAGRN/A

Historical CAGR

Year	1Y CAGR	2Y CAGR	3Y CAGR	5Y CAGR	10Y CAGR	15Y CAGR	20Y CAGR	30Y CAGR
FY 2025 Dec 31, 2025	644.9%	566.3%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2024 Dec 31, 2024	496.0%	N/A	N/A	28.3%	N/A	N/A	N/A	N/A
FY 2023 Dec 31, 2023	N/A	N/A	N/A	3.8%	N/A	N/A	N/A	N/A
FY 2022 Dec 31, 2022	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2021 Dec 31, 2021	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2020 Dec 31, 2020	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2019 Dec 31, 2019	106.7%	31.1%	33.9%	N/A	N/A	N/A	N/A	N/A
FY 2018 Sep 30, 2018	-16.9%	7.7%	N/A	N/A	N/A	N/A	N/A	N/A
FY 2017 Sep 30, 2017	39.7%	N/A	N/A	N/A	N/A	N/A	N/A	N/A
FY 2016 Sep 30, 2016	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Growth Analysis - AUTL

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Autolus Therapeutics plc

Compare with peers

Explore

Growth Analysis - AUTL

Financial Metrics

Revenue Trends

CAGR Performance

Revenue

Net Income

EPS

EBIT

EBITDA

Capex

Equity

Cash Flow

Historical CAGR

More on Autolus Therapeutics plc

Compare with peers

Explore